Skip to main content

Neeti Wilson speaks on ‘Patents, Innovation and Access to New Pharmaceuticals’ at the National Conference on IPR in Health Sciences organised by Amity University.

The two day conference, attended by over 150 participants, brought together speakers from the legal fraternity, government, and luminaries from the scientific community and academia.

Neeti spoke about the International System of Patenting and Indian patent law, with a focus on Section 3(d) of the Patents Act 1970.

In addition to talks on pharmaceutical patents and the role of regulation in health sciences, the conference envisaged discussion on topics ranging widely from IP in traditional medicine to patenting of cutting-edge medical developments such as regenerative medicines and stem cell research.neeti wilson amity university national conference ipr health sciences

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Sep 29, 2026

A person’s identity was once understood as something inseparable from the person. In the digital economy, it can also become an asset: a name that

Right to Publicity in India: From Celebrity Image to AI-Generated Identity
News & Updates, Thought Leadership
•
Sep 25, 2026

India’s startup ecosystem is becoming increasingly innovation-led, and the country’s intellectual property numbers offer an interesting glimpse into

India’s IP Numbers Tell a Bigger Story  About Startup Founders in India
News & Updates, Thought Leadership
•
Sep 21, 2026

First published by Asialaw. By: Lakshmidevi Somanath The law currently provides creators exclusive rights over their creation for a limited time, which

From Innovation Incentives to Technology Diffusion: Protecting IP Created by Agentic AI
News & Updates, Thought Leadership
•
Sep 21, 2026

First published by Lexology. Authors: Lakshmidevi Somanath and Kanishka Vaish I. INTRODUCTION The analysis of intellectual property licensing has usually

IP Licenses in Hybrid form and Royalty Payments Post-Patent Expiration: Balancing Patent Expiration and Continuing Rights to Trade Secrets and Know-How